Philippines - English - FDA (Food And Drug Administration)

blue sky trading co., inc. - diethylcarbamazine citrate - film coated tablet - 50mg

Philippines - English - FDA (Food And Drug Administration)

blue sky trading co., inc - terbutaline sulfate - tablet - 5mg

Philippines - English - FDA (Food And Drug Administration)

blue sky trading co., inc. - naproxen sodium - film-coated tablet - 550mg

Philippines - English - FDA (Food And Drug Administration)

blue sky trading co., inc.; distributor: blue sky trading co., inc. - meglumine ioxitalamate - solution for iv injection - 300 i/ml

Philippines - English - FDA (Food And Drug Administration)

blue sky trading co., inc.; distributor: blue sky trading co., inc. - iodized oil fluid - capsule - 500mg

Philippines - English - FDA (Food And Drug Administration)

blue sky trading co., inc.; distributor: blue sky trading co., inc. - iodized oil fluid - fluid for injection - 480 mg/ml(4.8g/10ml)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - ci acid blue 9, disodium salt (hidacid azure blue 65%) - liquid - ci acid blue 9, disodium salt (hidacid azure blue 65%) dye-blue active 90.0 g/l - marker - boomspray | fertiliser additive | fungicide marking additive | knapsack application | pesticide additive - dye marker

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - methylene blue, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - methylene blue injection usp is indicated: for the treatment of drug-induced methaemoglobinaemia; for the treatment of idiopathic methaemoglobinaemia (in which structural abnormality of haemoglobin is not present); as a bacteriological strain as a dye in diagnostic procedures such as fistula detection; for the delineation of certain body tissues during surgery.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agritrading pty limited - atrazine - water dispersible granule - atrazine triazine active 900.0 g/kg - herbicide - broom millet | broom millet - dryland | broom millet - irrigated | canola - tt only - post sowing, pre emer | canola(tt varietie - african star grass | amaranth or amaranthus | annual grass weed - suppression | annual ryegrass | annual ryegrass - suppression | barley grass | barley grass - suppression | barnyard or water grass | bellvine | billygoat weed or blue top | black bindweed | blackberry nightshade | bladder ketmia | broadleaf weeds | broadleaf weeds - see label | broadleaf weeds and grasses | brome grass | brome grass - suppression | budda or butter pea | burr | caltrop or yellow vine | capeweed | charlock | chinese burr | clover | cobbler's pegs | common sida | common thornapple | corn gromwell, ironweed or sheepweed | crowsfoot grass | cruciferous weed | dock | dwarf marigold | fat hen | feathertop rhodes grass | flannel weed - sida cordifolia | fleabane | fumitory | gambia pea | geranium | giant or black pigweed | giant sensitive plant | green summer grass | ground or annual ground cherry | ivy leaf speedwell | london rocket | loosestrife | lovegrass | medic | mexican or prickly poppy | mintweed | mossman river grass / spiny

United States - English - NLM (National Library of Medicine)

nelco laboratories, inc. - bluefish (unii: 79u8p8x3q5) (bluefish - unii:79u8p8x3q5) - bluefish 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t